Skip to content

CB1R in Synthetic Psychoactive Cannabinoids

CB1R Availability in Synthetic Psychoactive Cannabinoid Users

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03539575
Acronym
CB1R in Spice
Enrollment
15
Registered
2018-05-29
Start date
2018-05-01
Completion date
2026-12-01
Last updated
2026-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Dependence

Keywords

K2, Spice, Synthetic Marijuana

Brief summary

The purpose of this research study is to determine whether the CB1R availability is lower in synthetic psychoactive cannabinoid subjects using the most widely available synthetic psychoactive cannabinoids at the time the study is initiated.

Interventions

The radiotracer, \[11-C\]OMAR will be administered at no more than 10 micrograms at the beginning of each PET scan.

Sponsors

Yale University
Lead SponsorOTHER
National Institutes of Health (NIH)
CollaboratorNIH
National Institute on Drug Abuse (NIDA)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

Inclusion: * Able to provide written consent * Age 18-55 * Current Synthetic Psychoactive Cannabinoids consumption Exclusion: * MRI metal exclusions and claustrophobia * Education completed is less than 12 years

Design outcomes

Primary

MeasureTime frameDescription
Positron Emission Tomography (PET Imaging)Change in CB1R availability from baseline throughout one test dayCB1R availability using \[11-C\]OMAR PET imaging Change in CB1R availability (e.g. volume distribution).

Secondary

MeasureTime frameDescription
CogState BatteryChange in CB1R availability from baseline throughout one test day2\. Changes in Cognition during withdrawal using a computerized battery Changes in cognitive functions such as attention, memory, motor functioning, and processing speed.
ElectroencephalogramChange in CB1R availability from baseline throughout one test day3\. Changes in brain rhythms measured by Electroencephalography Changes in electroencephalographic (EEG) brain rhythms related to information processing.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORDeepak C D'Souza, M.D.

Yale University

PRINCIPAL_INVESTIGATORMohini Ranganathan, M.D.

Yale University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 30, 2026